However, for future applications especially for possible cancer treatments, the finding that LUBAC as well as ABIN-1 are strongly involved in regulation of TRAIL-based NF-κB signaling in HEK293 cells could lead to new therapeutic options. This evidence concerns the gene TNFSF10 and cancer.